Gene therapy for bone healing

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Evans, Christopher H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AO FOUNDATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; LENTIVIRUS VECTOR; OSTEOGENIC PROTEIN 1; PLASMID DNA; RETROVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN; VASCULOTROPIN A;

BONE DEFECT; EX VIVO GENE TRANSFER; FRACTURE HEALING; GENE THERAPY; GENE VECTOR; HUMAN; IN VIVO GENE TRANSFER; MEDICAL RESEARCH; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOLOGICAL MODEL; BONE; FRACTURE; GENETICS; INJURY; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WOUND HEALING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; FRACTURES, BONE; GENE THERAPY; HUMANS; MODELS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77955485475     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399410001493     Document Type: Review

References (110)

1. Kwiatkowski, T.C., Hanley, E.N., Jr and Ramp, WK. (1996) Cigarette smoking and its orthopedic consequences. American Journal of Orthopedics (Belle Mead NJ) 25, 590-597
2. Chakkalakal, D.A. (2005) Alcohol-induced bone loss and deficient bone repair. Alcoholism Clinical and Experimental Research 29, 2077-2090
3. Gandhi, A. et al. (2006) Diabetic fracture healing. Foot and Ankle Clinics 11, 805-824 (Pubitemid 44693393)
4. Gruber, R. et al. (2006) Fracture healing in the elderly patient. Experimental Gerontology 41, 1080-1093 (Pubitemid 44820727)
5. Giannoudis, P. et al. (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38, S90-99 (Pubitemid 46440934)
6. McKee, M.D. (2006) Management of segmental bony defects: the role of osteoconductive orthobiologics. Journal of the American Academy of Orthopaedic Surgeons 14, S163-167
7. Daniels, A.H. et al. (2008) Adverse events associated with anterior cervical spine surgery. Journal of the American Academy of Orthopaedic Surgeons 16, 729-738
8. Kim, D.H. et al. (2009) Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine Journal 9, 886-892
9. Delloye, C. et al. (2007) Bone allografts: What they can offer and what they cannot. Journal of Bone and Joint Surgery. British Volume 89, 574-579 (Pubitemid 46958761)
10. Watson, J.T. (2005)Overview of biologics. Journal of Orthopaedic Trauma 19, S14-S16
11. Shapiro, F. (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. European Cells and Materials 15, 53-76
12. Simpson, A.H., Mills, L. and Noble, B. (2006) The role of growth factors and related agents in accelerating fracture healing. Journal of Bone and Joint Surgery. British Volume 88, 701-705 (Pubitemid 43971130)
13. Lieberman, J.R., Daluiski, A. and Einhorn, T.A. (2002) The role of growth factors in the repair of bone. Biology and clinical applications. Journal of Bone and Joint Surgery. American Volume 84, 1032-1044
14. Tsumaki, N. and Yoshikawa, H. (2005) The role of bone morphogenetic proteins in endochondral bone formation. Cytokine and Growth Factor Reviews 16, 279-285 (Pubitemid 40910317)
15. Kwong, F.N. and Harris, M.B. (2008) Recent developments in the biology of fracture repair. Journal of the American Academy of Orthopaedic Surgeons 16, 619-625
16. Gillet, J.P. et al. (2009) The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer. Methods in Molecular Biology 542, 5-54
17. Evans, C.H. et al. (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proceedings of the National Academy of Sciences of the United States of America 102, 8698-8703 (Pubitemid 40862798)
18. Fiandaca, M., Forsayeth, J. and Bankiewicz, K. (2008) Current status of gene therapy trials for Parkinson's disease. Experimental Neurology 209, 51-57
19. Carofino, B.C. and Lieberman, J.R. (2008) Gene therapy applications for fracture-healing. Journal of Bone and Joint Surgery. American Volume 90, 99-110 (Pubitemid 351329128)
20. Peng, H. et al. (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. Journal of Clinical Investigation 110, 751-759
21. Koh, J.T. et al. (2008) Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. Journal of Dental Research 87, 845-849
22. Zhu, W. et al. (2004) Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. Journal of Bone and Mineral Research 19, 2021-2032 (Pubitemid 41103417)
23. Li, B.C. et al. (2009) Treatment of rabbit femoral defect by firearm with BMP-4 gene combined with TGF-beta1. Journal of Trauma 66, 450-456
24. Zhao, Z. et al. (2007) Healing cranial defects with AdRunx2-transduced marrow stromal cells. Journal of Dental Research 86, 1207-1211
25. Tu, Q. et al. (2007) Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Engineering 13, 2431-2340
26. Boden, S.D. et al. (1998) LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 139, 5125-5134 (Pubitemid 28533461)
27. Sangadala, S. et al. (2006) LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. Journal of Biological Chemistry 281, 17212-17219
28. Boden, S.D. et al. (1998) Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine (Phila. PA 1976) 23, 2486-2492
29. Viggeswarapu, M. et al. (2001) Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. Journal of Bone and Joint Surgery. American Volume 83, 364-376 (Pubitemid 32221566)
30. Lattanzi, W. et al. (2008) Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Therapy 15, 1330-1343
31. Parrilla, C. et al. (2009) Ex vivo gene therapy using autologous dermal fibroblasts expressing hLMP3 for rat mandibular bone regeneration. Head and Neck 32, 310-318
32. Pola, E. et al. (2004) Efficient bone formation by gene transfer of human LIM mineralization protein-3. Gene Therapy 11, 683-693 (Pubitemid 38519276)
33. Wan, D.C. et al. (2007) Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. Journal of Biological Chemistry 282, 26450-26459 (Pubitemid 47443797)
34. Kwong, F.N., Richardson, S.M. and Evans, C.H. (2008) Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Research and Therapy 10, R65.
35. Baltzer, A.W. et al. (2001) Gene therapy for osteoporosis: evaluation in a murine ovariectomy model. Gene Therapy 8, 1770-1776 (Pubitemid 34100577)
36. Bolon, B. et al. (2001) Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. Molecular Therapy 3, 197-205 (Pubitemid 32509822)
37. Kostenuik, P.J. et al. (2004) Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone 34, 656-664 (Pubitemid 38393801)
38. Shen, F.H. et al. (2002) Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. Journal of Orthopaedic Trauma 16, 651-659 (Pubitemid 35214856)
39. Young, L.S. et al. (2006) Viral gene therapy strategies: frombasic science to clinical application. Journal of Pathology 208, 299-318 (Pubitemid 43126122)
40. Kohn, D.B., Sadelain, M. and Glorioso, J.C. (2003) Occurrence of leukaemia following gene therapy of X-linked SCID. Nature Reviews Cancer 3, 477-488 (Pubitemid 37328836)
41. Kurian, K.M., Watson, C.J. and Wyllie, A.H. (2000) Retroviral vectors. Molecular Pathology 53, 173-176 (Pubitemid 30603070)
42. Sarkis, C. et al. (2008) Non-integrating lentiviral vectors. Current Gene Therapy 8, 430-437
43. Douglas, J.T. (2007) Adenoviral vectors for gene therapy. Molecular Biotechnology 36, 71-80
44. Frank, K.M. et al. (2009) Investigation of the cause of death in a gene-therapy trial. New England Journal of Medicine 361, 161-169
45. McCarty, D.M., Monahan, P.E. and Samulski, R.J. (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 8, 1248-1254 (Pubitemid 32780813)
46. Glover, D.J., Lipps, H.J. and Jans, D.A. (2005) Towards safe, non-viral therapeutic gene expression in humans. Nature Reviews Genetics 6, 299-310 (Pubitemid 40469049)
47. Evans, C.H. et al. (2009) Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. European Cells and Materials 18, 96-111
48. Gafni, Y. et al. (2004) Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Molecular Therapy 9, 587-595 (Pubitemid 38578809)
49. Rosenberg, S.A. et al. (1990) Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New England Journal of Medicine 323, 570-578 (Pubitemid 20260084)
50. Lieberman, J.R. et al. (1999) The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. Journal of Bone and Joint Surgery. American Volume 81, 905-917 (Pubitemid 29354999)
51. Lieberman, J.R. et al. (1998) Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. Journal of Orthopaedic Research 16, 330-339 (Pubitemid 28337629)
52. Breitbart, A.S. et al. (1999) Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Annals of Plastic Surgery 42, 488-495 (Pubitemid 29218313)
53. Peterson, B. et al. (2005) Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Engineering 11, 120-129 (Pubitemid 40515180)
54. Hsu, W.K. et al. (2008) Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. Journal of Bone and Joint Surgery. American Volume 90, 1043-1052 (Pubitemid 351632649)
55. Lee, J.Y. et al. (2001) Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. Journal of Bone and Joint Surgery. American Volume 83, 1032-1039
56. Ishihara, A. et al. (2010) Dermal fibroblastmediated BMP2 therapy to accelerate bone healing in an equine osteotomy model. Journal of Orthopaedic Research 28, 403-411
57. Shin, J.H. et al. (2010) Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats. Journal of Clinical Periodontology. 37, 305-311
58. Gugala, Z. et al. (2003) Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Therapy 10, 1289-1296 (Pubitemid 36987119)
59. Virk, M.S. et al. (2008) Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 42, 921-931
60. Gazit, D. et al. (1999) Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. Journal of Gene Medicine 1, 121-133 (Pubitemid 129631069)
61. Evans, C.H. et al. (2007) Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Engineering 13, 1987-1993 (Pubitemid 47293994)
62. Bosch, P. et al. (2000) Osteoprogenitor cells within skeletal muscle. Journal of Orthopaedic Research 18, 933-944 (Pubitemid 32063039)
63. Dragoo, J.L. et al. (2005) Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plastic and Reconstructive Surgery 115, 1665-1673 (Pubitemid 40604737)
64. Pelled, G. et al. (2009). Direct Gene Therapy for Bone Regeneration: Gene Delivery, Animal Models and Outcome Measures. Tissue Engineering Part A [Epub ahead of print: 21 Jul 2009]
65. Betz, O.B. et al. (2007) Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Therapy 14, 1039-1044 (Pubitemid 46965273)
66. Betz, O.B. et al. (2006) Direct percutaneous gene delivery to enhance healing of segmental bone defects. Journal of Bone and Joint Surgery. American Volume 88, 355-365 (Pubitemid 43185138)
67. Betz, V.M. et al. (2007) Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. Human Gene Therapy 18, 907-915 (Pubitemid 47587317)
68. Baltzer, A.W. et al. (2000) Genetic enhancement of fracture repair: healing of an experimental segmental defect byadenoviral transfer of the BMP-2 gene. Gene Therapy 7, 734-739 (Pubitemid 30255754)
69. Bertone, A.L. et al. (2004) Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. Journal of Orthopaedic Research 22, 1261-1270 (Pubitemid 39317917)
70. Ishihara, A. et al. (2008) Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. Journal of Orthopaedic Research 26, 764-771
71. Ito, T. et al. (2003) Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing. Gene Therapy 10, 1623-1628 (Pubitemid 37063269)
72. Egermann, M. et al. (2006) Effect of BMP-2 gene transfer on bone healing in sheep. Gene Therapy 13, 1290-1299 (Pubitemid 44264083)
73. Egermann, M. et al. (2006) Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Human Gene Therapy 17, 507-517 (Pubitemid 43794490)
74. Fang, J. et al. (1996) Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proceedings of the National Academy of Sciences of the United States of America 93, 5753-5758 (Pubitemid 26190752)
75. Bonadio, J. et al. (1999) Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nature Medicine 5, 753-759 (Pubitemid 29318608)
76. Geiger, F. et al. (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. Journal of Bone and Mineral Research 20, 2028-2035 (Pubitemid 41532788)
77. Endo, M. et al. (2006) Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Engineering 12, 489-497 (Pubitemid 43673454)
78. Huang, Y.C. et al. (2005) Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Therapy 12, 418-426
79. Ono, I. et al. (2004) Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. Biomaterials 25, 4709-4718 (Pubitemid 38561158)
80. Valimaki, V.V. et al. (2005) Molecular biological evaluation of bioactive glass microspheres and adjunct bone morphogenetic protein 2 gene transfer in the enhancement of new bone formation. Tissue Engineering 11, 387-394
81. Chang, P.C. et al. (2009) Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Human Gene Therapy 20, 486-496
82. Sonobe, J. et al. (2004) Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response. Human Gene Therapy 15, 659-668 (Pubitemid 38925218)
83. Ito, H. et al. (2005) Remodeling of cortical bone allografts mediated byadherent rAAV-RANKL and VEGF gene therapy. Nature Medicine 11, 291-297 (Pubitemid 40460557)
84. Koefoed, M. et al. (2005) Biological effects of rAAV-caAlk2 coating on structural allograft healing. Molecular Therapy 12, 212-218 (Pubitemid 41025090)
85. Shore, E.M. et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics 38, 525-527
86. Backstrom, K.C. et al. (2004) Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene. American Journal of Veterinary Research 65, 1223-1232 (Pubitemid 39232596)
87. Evans, C.H., Ghivizzani, S.C. and Robbins, P.D. (2008) Arthritis gene therapy's first death. Arthritis Research and Therapy 10, 110.
88. Raper, S.E. et al. (2003) Fatal systemic inflammatory response syndromein a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Molecular Genetics and Metabolism 8, 148-158 (Pubitemid 37272241)
89. Xu, G. et al. (2007) Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Research 17, 240-248 (Pubitemid 46438724)
90. Tsuchida, H. et al. (2003) Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. Journal of Orthopaedic Research 21, 44-53 (Pubitemid 36157619)
91. Yi, Y. et al. (2009) Irradiated human chondrocytes expressing bone morphogenetic protein 2 promote healing of osteoporotic bone fracture in rats. Tissue Engineering Part A 15, 2853-2863
92. Tarkka, T. et al. (2003) Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. Journal of Gene Medicine 5, 560-566 (Pubitemid 40310399)
93. Li, R. et al. (2009) Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. Journal of Orthopaedic Research 27, 8-14
94. Shen, H.C. et al. (2004) Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. Journal of Gene Medicine 6, 984-991
95. Hsu, W.K. et al. (2007) Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 40, 931-938 (Pubitemid 46386528)
96. Guo, X. et al. (2006) Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Biomedical Materials 1, 93-99 (Pubitemid 44529332)
97. Hidaka, C. et al. (2003) Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine 28, 2049-2057 (Pubitemid 37140191)
98. Hasharoni, A. et al. (2005) Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. Journal of Neurosurgery Spine 3, 47-52
99. Riew, K.D. et al. (1998) Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcified Tissue International 63, 357-360 (Pubitemid 28443422)
100. Park, J. et al. (2003) Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Therapy 10, 1089-1098 (Pubitemid 36850231)
101. Southwood, L.L. et al. (2004) Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. Journal of Orthopaedic Research 22, 66-72 (Pubitemid 38035447)
102. Ashinoff, R.L. et al. (2004) Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Annals of Plastic Surgery 52, 585-591 (Pubitemid 38697521)
103. Alden, T.D. et al. (2000) The use of bone morphogenetic protein gene therapy in craniofacial bone repair. Journal of Craniofacial Surgery 11, 24-30 (Pubitemid 30064158)
104. Rundle, C.H. et al. (2003) In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. Bone 32, 591-601 (Pubitemid 37297383)
105. Rundle, C.H. et al. (2008) Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat. Journal of Gene Medicine 10, 229-241 (Pubitemid 351359636)
106. Strohbach, C.A. et al. (2008) LMP-1 retroviral gene therapy influences osteoblast differentiation and fracture repair: a preliminary study. Calcified Tissue International 83, 202-211
107. Dai, K.R. et al. (2005) Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcified Tissue International 77, 55-61 (Pubitemid 41504173)
108. Xu, X.L. et al. (2005) Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthopaedica 76, 637-646 (Pubitemid 41551539)
109. Tang, T.T. et al. (2007) Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. Journal of Bone and Joint Surgery. British Volume 89, 127-129
110. Chang, S.C. et al. (2009) Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials. Neurosurgery 65, 75-83